TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

Funding News - Pluripotent Stem Cells

Archive folder iconHistorical Data

  • The information on this page is for historical and research purposes only.
  • For the most current NINDS funding announcements, please see the NINDS list of Active Funding Initiatives or Follow Us on Twitter for the latest funding news.

The National Institute of Neurological Disorders and Stroke (NINDS) encourages applications for research on the characterization, behavior, and plasticity of pluripotent stem cells. This announcement is made together with 6 other components of the National Institutes of Health (NIH).

Stem cell research offers enormous potential for treating a host of congenital, developmental, psychiatric, and degenerative diseases for which there are no cures.  In animal studies, multipotent progenitor cells from many different sources have been reported to generate cells with neuronal or glial properties, raising expectations that they could be used to replace lost neurons and glia, repair defective circuits, and restore functions compromised by abnormal development, age, physical damage, disease, or drug addiction.  In addition, the ability to selectively produce one or more differentiated cell types from pluripotent stem cells would help in discovering the effects of drugs and environmental and genetic factors on differentiation and cell function in the human nervous system.

For more information, potential applicants should contact Dr. David Owens, Program Director, Repair and Plasticity Cluster, NINDS; telephone: 301-496-1447; e-mail:  For a more detailed description of this announcement, visit